To investigate the development of coagulation regulatory proteins-protein C (PC), protein S (PS), and antithrombin (AT)-in relationship to the procoagulant protein factor X (FX), a chronically catheterized fetal ovine model was used. Infusion and sampling catheters were placed into pregnant ewes and their fetuses and maintained from mid-gestation. From a total of 110 fetuses, 17 lambs, and 63 ewes that were studied on one to 15 occasions, 212 fetal, 88 neonatal, and 157 maternal samples were obtained. Liver tissue was obtained from 31 fetuses and 15 ewes. Plasma levels of all proteins studied were higher in the ewe than in the fetus (p Ͻ 0.0001). Plasma levels of FX, PC, and PS achieved neonatal levels by mid-gestation with mild but significant decreases during mid-and late gestation. Fetal and early neonatal plasma concentrations of these vitamin K-dependent proteins fit a model with both quadratic (p Ͻ 0.01) and linear (p Ͻ 0.01) components. The discrepant levels in mRNA relative to plasma concentration were consistent with regulatory control beyond the level of transcription. In contrast, a simple linear increase in plasma protein levels was determined for the vitamin K-independent coagulation regulatory protein, AT (p for quadratic component Ͼ 0.05). This study suggests that fetal regulation of coagulation proteins follows characteristic patterns relative to the vitamin K dependence of the protein rather than its role as a procoagulant versus regulatory protein. The hemostatic systems of the fetus and neonate differ from that of the adult. Plasma concentrations of coagulation proteins mature at different rates during in utero and postnatal development (1-3). In particular, vitamin K-dependent factors, prothrombin, PC, PS, and factors VII, IX, and X, as well as contact factors XI, XII, prekallikrein, and high-molecular-weight kininogen, are present in very low concentrations in the fetus and do not achieve normal adult levels until later infancy to adolescence (2-7). Clinically, the well neonate has a functionally intact hemostatic system. However, the stressed infant demonstrates an increased predisposition to thrombosis, both induced and spontaneous (8). The increased rate of thrombosis in neonates is generally attributed to physiologically low levels of coagulation regulatory proteins, particularly PC, PS, and AT.
The hemostatic systems of the fetus and neonate differ from that of the adult. Plasma concentrations of coagulation proteins mature at different rates during in utero and postnatal development (1) (2) (3) . In particular, vitamin K-dependent factors, prothrombin, PC, PS, and factors VII, IX, and X, as well as contact factors XI, XII, prekallikrein, and high-molecular-weight kininogen, are present in very low concentrations in the fetus and do not achieve normal adult levels until later infancy to adolescence (2) (3) (4) (5) (6) (7) . Clinically, the well neonate has a functionally intact hemostatic system. However, the stressed infant demonstrates an increased predisposition to thrombosis, both induced and spontaneous (8) . The increased rate of thrombosis in neonates is generally attributed to physiologically low levels of coagulation regulatory proteins, particularly PC, PS, and AT.
PC is a vitamin K-dependent serine protease that serves a critical role in the regulation of coagulation. Activated PC, with its cofactor PS, inactivates activated procoagulant factors V and VIII (9) . Infants with severe genetic deficiencies of either PC or PS manifest spontaneous thrombosis in utero or within hours of birth (10, 11) . Our previous work showed that the mean concentration of PC in the extremely preterm infant is 0.20 U/mL, as compared with 1.00 U/mL in healthy adults (6, 7) . An increased risk of catheter-related and spontaneous thrombosis was demonstrated in preterm infants with plasma concentrations of PC Ͻ0.10 U/mL (7) .
AT is an essential regulatory protein that functions through inhibition of coagulation serine proteases, including activated factors IX, X, XI, and thrombin (12) . The formation of complexes of procoagulant proteins with AT is accelerated 1000-fold by heparin (12) . Newborn infants have been shown to have approximately 50% adult plasma concentration of a functionally normal AT (6, 13) . Heparin resistance, or failure to achieve a plasma anti-Xa activity commensurate with therapeutic heparin infusion rate, is commonly found in infants and ascribed to low neonatal levels of AT (14 -16) . Complete absence of AT appears to be incompatible with life, as there are no infants known to have survived with this condition. In addition, mouse gene "knock-out" models of homozygous AT deficiency show embryonic lethality (17) . Heterozygous deficiencies of AT in human infants have been associated with thrombi in the perinatal period (18, 19) .
To date, it has not been determined whether a biochemical balance exists between procoagulant and anticoagulant proteins during normal fetal development. To prevent or treat bleeding or clotting complications in sick preterm infants, it is necessary to understand physiologic regulation of coagulation proteins during ontogeny. Plasma levels of procoagulant proteins have been studied in various animal models during fetal and neonatal development (20) . In contrast, developmental expression of regulatory proteins has not been well studied.
Previous investigations by the authors used a chronically catheterized model of ovine gestation to study molecular forms of PC (21) . In that work, fetal ovine plasma PC levels were reported at 25-75% of nonpregnant, healthy, adult sheep (21) . The current studies were designed to meet two objectives. The first was to extend the original observations regarding the development of PC in the stable ovine fetus, neonatal lamb, and pregnant ewe. The second objective was to compare ontogeny of PC with the vitamin K-dependent regulatory protein, PS; the vitamin K-dependent procoagulant protein, FX; and the vitamin K-independent regulatory protein, AT, in the ovine model.
METHODS
Concentrations of PC, PS, FX, and AT in plasma and abundance of mRNA for PC, PS, and AT in hepatic tissue were determined on samples obtained from a cohort of healthy pregnant ewes, their fetuses, and neonatal lambs. This cohort included samples from animals that were previously reported in a study of molecular structure of fetal ovine PC (21) as well as additional study animals forming a larger cohort. Results of ovine PS, FX, and AT from this ovine cohort have not been previously reported by the authors.
Preparation of the Animal Model
Columbia-Rambouillet pregnant sheep with known gestational age (from induced ovulation) were operated on between 70 and 120 d gestation to place maternal arterial sampling and venous infusion catheters or at approximately 120 d for placement of both maternal and fetal arterial sampling catheters and venous infusion catheters. Surgery was performed using either of two anesthesia protocols: i.v. pentobarbital sedation (15 mg/kg) and spinal anesthesia (tetracaine HCl, 10 mg in hypertonic glucose) for the surgery at 120 d gestation or intramuscular acetylpromazine (1 mg/kg) with i.v. ketamine anesthesia (12-15 mg/kg loading dose with 0.3-0.5 mg/kg/min continuous infusion) for the surgery at 70 -80 d gestation. Maternal sampling catheters were placed into the femoral artery and infusion catheters were placed into the femoral vein as previously described (21, 22) . Fetal catheters were placed via hind limb vessels into the abdominal aorta and the left hepatic vein for sampling and into the inferior vena cava for infusion, as previously described (21, 22) . All catheters were tunneled subcutaneously to exit the mother through a flank incision and kept within a plastic pouch attached to the maternal flank. The catheters were flushed daily to every other day with 0.9% wt/vol NaCl in H 2 O that contained 30 U/mL sodium heparin. After surgery, the sheep were allowed to recover at least 4 d before study. Healthy chronically catheterized pregnant ewes were allowed an ad libitum diet of alfalfa pellets, water, and mineral supplements. All protocols were approved by the Institutional Animal Care and Use Committee of the University of Colorado Health Sciences Center (UCHSC). All animal procedures were conducted at the UCHSC Perinatal Research Center, which is accredited by the National Institutes of Health, the United States Department of Agriculture, and the American Association for the Accreditation of Laboratory Animal Care.
Blood samples were collected from the ewe and her fetus or neonatal lamb on one or more occasions. The catheters were first cleared by removing 3 mL of blood, and then 0.9 mL blood samples were drawn into 0.1 mL of 3.8% sodium citrate anticoagulant. The samples were centrifuged at 1800 ϫ g for 20 min at 4°C. Aliquots of plasma were subsequently frozen at Ϫ70°C until the time of assay.
Laboratory Methods
Assays of plasma protein concentrations. To develop immunologic assays for ovine PC, PS, and FX, the coagulation proteins were purified from normal sheep plasma. Ovine PC was purified using barium chloride precipitation, EDTA elution, ammonium precipitation, and sequential chromatographies over diethylaminoethyl (DEAE) Sepharose, heparin Sepharose, and Blue Sepharose CL-6B as previously described (21) .
Ovine plasma FX and PS were purified using the same plasma source and chromatography columns as PC; however, different column eluent fractions were used for the purification. Column fractions were monitored with coagulation assay for factors II, VII, IX, X, and PC as previously described (21) . Column fractions for FX were selected by a FX protime-based clotting assay. PS fractions were selected by their relative molecular weights with silver stains of SDS-PAGE. A total of 130 10-mL fractions were eluted from the DEAE-Sephadex A50 column with a 1100 mL NaCl gradient (0.175-0.6 M). Fractions 60 -87 from the DEAE column containing PC, PS, FVII, and FIX were pooled to form DEAE "A." Fractions 88 -100 containing PC were pooled to form DEAE "B." As previously described (21) , DEAE "B" was further purified on blue Sepharose CL-6B and heparin Sepharose columns. DEAE fractions 105-120 containing FX were pooled to make DEAE "C." DEAE "C" was applied to a 16-mL blue Sepharose column and eluted with 50 mL NaCl gradient (0 -2 M) into 90 0.5-mL fractions. Fractions 3-35 were pooled, applied to a 14-mL heparin Sepharose column, and eluted with 0.1 M NaCl for concentration purposes. Five milliliter fractions were collected and tested for FX. Fractions 65-75 were pooled and used for antibody production. DEAE "A" was applied to a 55-mL blue Sepharose column and eluted with 450 mL NaCl gradient (0.1-4.1 M) into 90 5-mL fractions. Fractions 80 -90 were pooled, applied to a 90-mL heparin Sepharose column,
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and eluted with 800 mL NaCl gradient (0 -1 M) into 10-mL fractions. After testing, tubes 54 -70 were pooled and used for PS antibody production.
Plasma concentrations of ovine PC, PS, and FX were determined using rabbit anti-sheep polyclonal antibodies in a Laurell rocket assay. The proteins were used to immunize New Zealand White rabbits for production of polyclonal antibodies as previously described (22) . The resultant antibodies to PC, PS, and FX were partially purified and tested for specificity with the use of overloaded, crossed immunoelectrophoresis gels with ovine plasma, ovine PC, ovine PS, and ovine FX to detect cross-reactivity. The PS measurement was of total PS. AT activity was determined in a chromogenic assay as previously described (22) .
Assays to detect vitamin K deficiency. To estimate carboxylation of ovine PC, an immunologic assay for PIVKA-C was used as previously reported in neonatal lambs (23) . In performance of this assay, 0.5 mL of fetal ovine plasma anticoagulated in 3.8% sodium citrate was absorbed with 40 L of 1 M BaCl 2 to remove normal carboxylated PC. The plasma was mixed and, after incubation for 1 h at 4°C, was centrifuged at 3500 ϫ g for 10 min. The supernatant and the starting plasma were subjected to Laurell rocket immunoelectrophoresis using the rabbit anti-sheep ovine PC antibody. PC antigen concentration determined in the supernatant was reported as noncarboxylated PC, and PC antigen concentration determined in the starting plasma was reported as total PC.
Establishment of normal adult and gestational ovine plasma protein concentrations. Separate aliquots of frozen plasma were thawed for assay of PC, PS, FX, and AT. A standard ovine pool was prepared from 26 healthy, nonpregnant adult sheep (19 males and 7 females). Normal adult values for ovine PC, PS, FX, and AT were derived from these individual plasma samples, with the pool mean expressed as 1 U/mL. Study samples were read against curves constructed using dilutions of the normal ovine pool. Concentrations of coagulation proteins in the healthy ewes, fetuses, and lambs were evaluated over gestation and the neonatal period to determine and compare physiologic changes associated with gestation and the perinatal period.
Determination of mRNA for PC, PS, and AT. Liver tissue was obtained and processed for the purpose of determining abundance of mRNA for PC, PS, and AT as previously described (22) . RNA was isolated by the rapid method of Chomczynski and Sacchi (24) and analyzed by Northern blot hybridization. A 32 P-labeled 900-bp bovine cDNA probe was used as previously described (22) . Similarly, 32 P-labed 2.5 and 1.5 kbp bovine cDNA probes were used for PS and AT, respectively. A cDNA probe for ovine FX mRNA was not available.
Northern blot signals were quantified using scanning densitometry and normalized against the housekeeping gene ␤-actin. The results were reported as a percentage of a standard prepared using a pool of mRNA extracted from livers obtained from 15 healthy, nonpregnant ewes.
Data Analysis
A previous publication reported aggregate data regarding mean PC levels in ewes, fetuses, and lambs (21) . However, for this study, individual sample points were subjected to further mathematical analyses and compared with similar analyses for PS, FX, and AT.
These data were analyzed using a mixed model that accounted for the fact that there were repeated measures on some of the sheep. The first step of the analysis was to determine whether the levels of PC, PS, and FX antigen, as well as AT activity, differed with respect to the three groups: fetus, lamb, and ewe. If a statistically significant difference (p Ͻ 0.05) were detected in the initial model, then the second step was to add linear contrasts to the model. The linear contrasts allowed us to determine which pairs (e.g. fetus and lamb, fetus and ewe, and lamb and ewe) were significantly different. The third analytic step was to examine the relationship between gestational age and the level of each of the following: PC, PS, and FX antigen and AT activity. The group of ewes was excluded from this model. Based on the slightly U-shaped pattern of the plots, we tested for significant linear and quadratic components in each of the four models.
RESULTS
The study included 110 fetuses, 17 lambs, and 63 ewes from which we drew 212 fetal, 88 neonatal, and 157 maternal samples, respectively. Individual animals were studied on one to 15 occasions.
Protein C. Plasma samples from a subset of 15 ovine fetuses, ranging from 125 to 144 d gestation, were used to assay for noncarboxylated PC. Their plasma PC antigen ranged from 0.26 to 0.70 U/mL. No sample had detectable noncarboxylated PC. Figure 1 shows PC plasma concentrations in ovine fetuses, lambs, and ewes as a function of postconceptional age. The initial mixed model demonstrated that the levels of PC antigen were statistically significantly different among the three ovine groups. The mean levels of PC antigen among the fetuses, lambs, and ewes were 47.0 U/dL, 42.7 U/dL, and 97.4 U/dL, respectively. Using linear contrasts, we determined that the PC antigen levels did not differ significantly between the fetuses and lambs. We previously reported that lamb PC values were significantly lower than fetal levels when a smaller number of samples were analyzed (21). However, both groups had PC antigen levels that were significantly lower relative to the maternal levels (p Ͻ 0.0001). Given that fetal and lamb values differed from those of the ewes, we created a model to examine PC antigen levels relative to gestational age. Although the mean fetal and lamb levels of PC antigen did not differ, the individual measurements fit a model with linear (p ϭ 0.0074) and quadratic (p Ͻ 0.0077) components that evidenced a decrease in PC antigen as the fetus approached term and an increase in levels after birth.
Protein S. Figure 2 shows PS levels in ovine fetuses, lambs, and ewes as a function of postconceptional age. We used the same analytic methodology for PS as for PC described above; however, the results were slightly different. The model showed 582 that there were statistically significant differences in PS antigen levels among the three groups. Unlike PC antigen levels, the levels of PS antigen differed among all three pairs of groups (p Ͻ 0.0001 for each pair). The mean values of PS antigen were 45.6 U/dL, 74.4 U/dL, and 104.4 U/dL for the fetuses, lambs, and ewes, respectively. Similar to PC antigen, the fetal and lamb PS antigen levels also had linear (p Ͻ 0.0001) and quadratic terms (p Ͻ 0.0001) relative to gestational age. The model showed a rather dramatic increase in PS antigen that begins just before birth and continues after birth. The data also showed that many of the lamb levels fell within the range of maternal PS antigen.
Factor X. Figure 3 shows FX levels in ovine fetuses, lambs, and ewes as a function of postconceptional age. Just as with the PC and PS models, the FX model indicated that the fetal, lamb, and maternal FX antigen levels differed. The mean FX antigen levels were 24.1 U/dL for fetuses, 44.9 U/dL among lambs, and 108.2 U/dL for ewes. Again, linear contrasts supported that the apparent differences between these mean levels were statistically significant (p Ͻ 0.0001 for each pair of groups). Relative Antithrombin. Figure 4 shows levels of AT activity in ovine fetuses and ewes as a function of postconceptional age. AT activity levels were available only for fetuses and ewes. The mean fetal and maternal AT activity levels were statistically significantly different (p Ͻ 0.0001). The mean AT activity levels were 84. components. There was not a statistically significant relationship between gestational age and mRNA abundance for PS or AT.
DISCUSSION
The human preterm and term neonates show an increased predisposition to thrombosis compared with the older infant and child (8) . The increased incidence of thrombosis in the neonatal period has been ascribed to lower plasma concentrations of coagulation regulatory proteins secondary to physiologic immaturity.
Sheep have been used to model ontogeny of procoagulant proteins under conditions mimicking normal and pathologic states common to human infants (20 -22, 25-29) . In the studies presented in this article, the chronically catheterized fetal ovine model was used to investigate the development of various coagulation regulatory proteins from mid-gestation through the neonatal period. Surprisingly, we found that the plasma concentrations of PC at mid-gestation and at 3 wk postnatal age were nearly the same. We noted a slight but statistically significant decrease in PC concentration from 100 d gestation to just before delivery at term, with a slow rise subsequently. Similar patterns were found for vitamin K-dependent FX. Kisker et al. (26) studied the development of procoagulant proteins in the ovine fetus using functional clotting assays and reported consistent linear increases throughout gestation for procoagulant factors V, VIII, XI, XII, and XIII. Data displayed in this manuscript showed decreases in functional activities of prothrombin, factor VII, and fibrinogen during the middle of the third trimester (26) . Graphed data regarding FX in Kisker's 
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report did not show a decrease in FX during fetal development, but analysis of the data points was not reported or discussed (26) . We found a subtle but mathematically similar pattern of fetal plasma development for ovine procoagulant FX. Although our model is suggestive, more data are needed during early gestation to substantiate this observation. A crosssectional study of human fetal coagulation proteins showed early expression and delayed development of several coagulation proteins, especially prothrombin, factors IX and XI, PC, and PS. Factors V, VIII, and XII and AT showed continuous linear increases similar to the ovine model (3). The human fetal data were not modeled mathematically.
Total PS antigen was measured in this study. Free PS comprises the PS compartment not bound to C4b-binding protein. In the fetal blood sampling study of Moalic et al. (30) , C4b-binding protein in the human fetus ranged from 1.8% at 19 -23 wk gestation to 9.3% at 30 -38 wk gestation. As there is very little C4b-binding protein, it can be assumed that essentially all the PS is in the free form.
We showed a characteristic pattern of fetal development of coagulation proteins related to vitamin K dependence. However, this relationship is not exclusive to vitamin K-dependent proteins, as Kisker et al. (26) found this pattern for ovine fibrinogen and Reverdiau-Moalic et al. (3) determined similar fetal development for human factor XI.
We showed a comparable developmental pattern for vitamin K-dependent regulatory PC and total PS, but not for vitamin K-independent AT. In addition, we compared plasma results with abundance of hepatic mRNA for these proteins in the fetal lamb and pregnant ewe and found that decreases in plasma concentration of vitamin K-dependent proteins contrasted to relatively increased abundance of hepatic mRNA. Although we did not normalize the fetal liver data to account for hematopoietic cells that occupy hepatic mass, such correction would have magnified the increase in relative abundance of fetal mRNA for vitamin K-dependent coagulation proteins. Abundance of hepatic mRNA for PS was shown to be substantially higher than the maternal values in most samples throughout gestation. In contrast, nearly all of the fetal and lamb values of PC and AT hepatic mRNA abundance were below the maternal values. It is noted that late in the third trimester and during the peripartum period, abundance of mRNA for PC increased without a concordant increase in plasma PC concentration. The development of PC may follow a course similar to that of PS but with a later time to maturation. Relative abundance of mRNA for AT was shown to be equal to or less than the corresponding plasma concentrations for gestational age, whereas mRNA abundance for PC and PS was consistently higher than the plasma concentrations at the same gestational age.
Data regarding expression of procoagulant proteins during fetal development have been recently reviewed (3, 31) . The regulatory mechanisms are not completely understood. Plasma concentrations of most plasma proteins show continuous increases over time until the adult level is achieved and maintained. The development of ovine factors V, VIII, XI, XII, XIII, and AT fits this pattern. In addition, specific inducers of protein synthesis also are known. For example, vitamin Kdependent factor IX is known to have an androgen-responsive regulatory element (32) . The onset of puberty or treatment with androgens results in a striking increase in factor IX concentration in individuals with the factor IX Leyden mutation, a form of hemophilia B known to result from mutations in promoter sequences that interfere with binding of critical transcription factors (32, 33) . In addition, increases in corticosteroids around the time of human birth promote maturation of a number of proteins (34) . Indeed, Kisker et al. (35) showed increases in factors II, V, VII, and X in the fetal lamb after hydrocortisone infusions into the lamb or ␤-methasone treatment given to the ewe. It is tempting to speculate that steroid hormones play a role in the physiologic regulation of perinatal and later developmental changes in coagulation proteins.
Postnatal synthesis of most hepatic proteins is regulated by rate of transcription (36) . Hepatic protein synthesis has been 586 estimated by determination of abundance of mRNA for the protein of interest in relation to other proteins whose expression is known to be independent of gestational age. In addition, expression profiles of active genes have been determined by collection of sequences with a 3'-directed DNA library that mirrors the composition of the mRNA population. Such studies have demonstrated that synthesis of coagulation proteins is among the most active in the fetus after production of plasma proteins such as albumin (37) . Employing a methodology termed differential display reverse transcriptase-PCR, it has been shown that, in contrast to postnatal hepatic protein synthesis, approximately 99% of hepatic genes expressed during fetal development are not transcriptionally regulated, but most likely controlled at the level of translation (38) . Hassan et al. (39) demonstrated that by five weeks of gestation mRNA and intracellular proteins for coagulation factors VII, VIII, IX, X, fibrinogen, PC, and AT could be detected in hepatic cells of human embryos. Between 5 and 10 wk of fetal development, most coagulation mRNA increased from 30% to 50% of the normal adult level (39) . In this study, mRNA abundance for FX was equal to abundance in adult liver during the first trimester of gestation; intracellular concentration of FX in the hepatocyte was greater than that found in adult livers at this same time. Adsorption studies using barium citrate were consistent with intracellular ␥-carboxylation of hepatic FX. In contrast to cellular results, concomitant plasma concentration of FX antigen was 20 -40% of normal adult values, suggesting a block in FX secretion.
Regulation of vitamin K-dependent proteins may be unique. Karpatkin et al. (40, 41) documented expression of fetal hepatic mRNA for rabbit prothrombin equal to or greater than expression in adult liver while plasma concentrations of prothrombin remained low, similar to our findings for PS and our perinatal results for PC as well as the FX results of Hassan et al. (39) . The discordance between relative abundance of mRNA for vitamin K-dependent proteins and plasma concentrations supports that regulation is not at the level of gene transcription. Other possible explanations for the observed phenomena include decreased mRNA translation, ineffective protein synthesis, decreased intracellular protein stability, decreased protein secretion from the cell, secretion of unstable proteins with accelerated plasma elimination, or a nonspecific increase in protein catabolism.
PC undergoes complex post-translational modification including glycosylation, vitamin K-dependent ␥-carboxylation, and ␤-hydroxylation. We previously reported increased Nlinked glycosylation of fetal ovine PC (21) . Fetal fibrinogen is known to contain increased sialic acid, mannose, and phosphate relative to the adult molecular form (42) . It is possible that altered fetal glycosylation contributes to accelerated plasma elimination of PC and other vitamin K-dependent proteins. Andrew et al. (43) reported increased plasma elimination of both fetal and adult fibrinogen in the healthy newborn lamb, suggesting accelerated nonspecific protein turnover in the fetus. Karpatkin et al. (31) , however, were unable to detect any difference in plasma elimination of prothrombin in the newborn versus adult rabbit pup.
Vitamin K inhibition by warfarin has been shown to decrease protein antigen concentrations of dependent proteins in the plasma, as well as to result in dysfunctional molecules, suggesting a role of vitamin K in the regulation of protein synthesis (44 -47) . Experiments using HepG2 cells in culture demonstrated prothrombin secretion from the cell increased up to 100% and total prothrombin synthesis increased by 50% in the presence of excessive vitamin K1 (48) . Secretion of prothrombin decreased by 19% after warfarin exposure in this model. However, the total amount of prothrombin mRNA was unchanged by either vitamin K1 or warfarin exposure. These and other data suggest that vitamin K is not directly related to transcription, but secretion of prothrombin and other vitamin K-dependent proteins from the hepatocyte is linked to conformational changes that occur with ␥-carboxylation and is decreased in vitamin K deficiency states (45) (46) (47) (48) (49) (50) .
The placenta maintains a steep gradient of vitamin K during gestation, with fetal levels approximately one-10th that of maternal (51, 52) . Evidence for vitamin K deficiency at birth has been reported by many authors (52, 53) . It has been speculated that high concentrations of vitamin K promote mutagenesis of DNA in vitro, and low levels of vitamin K are maintained during fetal development to diminish mutagenic risk in rapidly proliferating cells (54) . Although we were unable to detect noncarboxylated PC in the subset of ovine fetuses studied, our assay may have been insensitive to partially carboxylated PC molecules. It is possible that diminished availability of hepatic vitamin K is an important physiologic regulator of plasma protein secretion in the ontogeny of the vitamin K-dependent proteins. Further studies are required to explore this possibility.
The current data support that vitamin K-dependent coagulation proteins, as a group, are characterized by early appearance and delayed fetal maturation of plasma concentration with physiologic hepatic regulation at a level beyond gene transcription. This pattern of ontogeny of plasma concentration of ovine vitamin K-dependent proteins is shared only by fibrinogen. Developmental rises during later gestation and perinatally are preceded by increased abundance of mRNA, suggesting altered translation, processing, secretion, or plasma half-life of these proteins. There is mounting evidence for a significant role of diminished secretion from the hepatocyte. The longest and most exaggerated delay is found in PC; this delay should account, at least in part, for the severe PC deficiency found in sick preterm infants and may predispose the newborn infant to thrombosis.
